A ‘modified de Gramont’ regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer
Open Access
- 6 August 2002
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 87 (4) , 393-399
- https://doi.org/10.1038/sj.bjc.6600467
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- Recommendation for Caution with Irinotecan, Fluorouracil, and Leucovorin for Colorectal CancerNew England Journal of Medicine, 2001
- High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)European Journal Of Cancer, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)European Journal Of Cancer, 1999
- CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1999
- Role of lymphatic mapping and sentinel node biopsy in melanoma detectionEuropean Journal Of Cancer, 1998
- CorrespondenceEuropean Journal Of Cancer, 1998
- Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment RegimensEuropean Journal Of Cancer, 1996
- High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1988